Sufferers found to have low levels of gut microbes that convert bile acids into other substances

Research has shown that the bacterial composition of the gut may differ in people with IBS. HMOs selectively nourish the “good bacteria,” enabling them to flourish and improve the body’s gut barrier.

Exploring the microbiome in GI diseases.

Fasting regimens have gained public and scientific interest in recent years, but fasting shouldn't be dismissed as a fad. In a study published in Cell, Mount Sinai researchers found that fasting reduces inflammation and improves chronic inflammatory diseases without affecting the immune system's response to acute infections.

During colonoscopy, air insufflation to distend the lumen and facilitate careful inspection and scope insertion can induce pain and cause discomfort. Carbon dioxide (CO[2] ) insufflation can decrease abdominal pain and discomfort during and after colonoscopy. ...

AbstractBackground and Aims:. Diagnostic delay is frequent in patients with Crohn’s disease (CD). We developed a tool to predict early diagnosis.Methods.

Irritable bowel syndrome (IBS), a common gastrointestinal disorder involving the gut-brain axis, and inflammatory bowel disease (IBD), a chronic relapsing inflammatory disorder, are both increasing in incidence and prevalence in Asia. Both have significant ...

Around 30% of patients with inflammatory bowel disease (IBD) are refractory to current IBD drugs or relapse over time. Novel treatments are called for, and low dose Naltrexone (LDN) may provide a safe, easily accessible alternative treatment option for ...

Predictive model to distinguish IBD from IBS via gut microbial composition data proved more accurate than did current fecal biomarker calprotectin.

Symptoms of IBD, such as abdominal pain and diarrhoea, frequently mimic or overlap those of irritable bowel syndrome [IBS] and therefore IBD patients with concomitant IBS pose a diagnostic and therapeutic dilemma for many physicians.

The research — the results of which appear in Frontiers in Nutrition — explains how E171 can alter the activity of gut bacteria in potentially dangerous ways.

Oral butyrate is safe and well tolerated, and may be effective in inducing clinical improvement/remission in Crohn's disease.

This may be surprising to many readers, but patients sometimes ask about having their colonoscopy done without any sedationl.

There is no cure for Crohn’s and no cause is officially recognised. However, we believe there is compelling evidence pointing to MAP as the cause of Crohn’s disease.

Doctors typically prescribe anti-inflammatory drugs to people suffering from inflammatory bowel diseases like Crohn’s or ulcerative colitis. These medications, however, leave much to be desired: they are often ineffective and can come with unpleasant side effects. What’s more, they tend to remedy the symptoms of the disease rather than fixing the underlying problem.

For those of you with IBD,the good bit for you is towards the end.

According to a new study, inflammatory bowel disease increases the risk of developing prostate cancer. This finding opens up a challenging clinical debate.

"The next step for our probiotic is to conduct clinical trials to demonstrate its efficacy in diseases, such as Crohn's, ulcerative colitis and irritable bowel syndrome as well as cancer," Ghannoum said. "If the efficacy is proven, the potential impact for people suffering with these devastating conditions is extremely exciting to me as a scientist.

Crohn’s disease, which may affect as many as 780,000 Americans, is a type of inflammatory bowel disease (IBD). The condition is defined by chronic inflammation of the gastrointestinal (GI) tract, most commonly the end of the small bowel (the ileum) and the beginning of the colon, but it may affect any part of the GI tract. It differs… Read More…